Johansen, N. D., Vaduganathan, M., Bhatt, A. S., Modin, D., Chatur, S., Claggett, B. L., Janstrup, K. H., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Køber, L., Solomon, S. D., Sivapalan, P., Jensen, J. U. S., Martel, C. J. M., Krause, T. G. & Biering-Sørensen, T. (2024). Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season. American Heart Journal, 272, 23-36. https://doi.org/10.1016/j.ahj.2024.03.003

the TransformCF study group (2024). Real-world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis. APMIS, 132(10), 728-733. https://doi.org/10.1111/apm.13453

Ammitzbøll, C., Thomsen, M. K., Andersen, J. B., Jensen, J. M. B., Bayarri-Olmos, R., Garred, P., Hermansen, M.-L. F., Johannsen, A. D., Larsen, M. L., Mistegaard, C. E., Mikkelsen, S., Nielsen, L., Olesen, R., Pérez-Alós, L., Vils, S. R., Szabados, F., Søgaard, O. S., Tolstrup, M., Erikstrup, C. ... Troldborg, A. (2024). Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients. Clinical and Experimental Rheumatology, 42(1), 157-165. https://doi.org/10.55563/clinexprheumatol/orpp04

Vittrup, S. Ø., Jensen, L. K., Hartmann, K. T., Aalbæk, B., Hanberg, P. E., Slater, J., Hvistendahl, M. A., Stilling, M., Jørgensen, N. P. & Bue, M. (2024). Rifampicin does not reduce moxifloxacin concentrations at the site of infection and may not improve treatment outcome of a one-stage exchange surgery protocol of implant-associated osteomyelitis lesions in a porcine model. Acta Pathologica et Microbiologica Scandinavica APMIS, 132(3), 198-209. https://doi.org/10.1111/apm.13371

Møller, M., Friis-Hansen, L., Kirkby, N., Dilling-Hansen, C., Andersson, M., Vedsted, P., Mølbak, K. & Koch, A. (2024). Robust immune response to COVID-19 vaccination in the island population of Greenland. Communications Medicine, 4(1), 173. Artikel 173. https://doi.org/10.1038/s43856-024-00602-y

Singh, K., Rubenstein, K., Callier, V., Shaw-Saliba, K., Rupert, A., Dewar, R., Laverdure, S., Highbarger, H., Lallemand, P., Huang, M.-L., Jerome, K. R., Sampoleo, R., Mills, M. G., Greninger, A. L., Juneja, K., Porter, D., Benson, C. A., Dempsey, W., El Sahly, H. M. ... Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members (2024). SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir. The Journal of Infectious Diseases, 230(3), 624-634. https://doi.org/10.1093/infdis/jiae198

Søndergaard, M. H., Thavarajah, J. J., Churchill Henson, H. & Wejse, C. M. (2024). SARS-CoV-2 vaccine immunogenicity for people living with HIV: A systematic review and meta-analysis. HIV Medicine, 25(1), 16-37. https://doi.org/10.1111/hiv.13537

Petersen, E., Al-Abri, S., Al-Jardani, A., Memish, Z. A., Aklillu, E., Ntoumi, F., Mwaba, P., Wejse, C., Zumla, A. & Al-Yaquobi, F. (2024). Screening for latent tuberculosis in migrants—status quo and future challenges. International Journal of Infectious Diseases, 141, Artikel 107002. https://doi.org/10.1016/j.ijid.2024.107002

Cham, L. B., Rosas-Umbert, M., Lin, L., Tolstrup, M. & Søgaard, O. S. (2024). Single-Cell Analysis Reveals That CD47 mRNA Expression Correlates with Immune Cell Activation, Antiviral Isgs, and Cytotoxicity. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 58(4), 322-335. https://doi.org/10.33594/000000715

ITIT Global Network (2024). Surveillance of global, travel-related illness using a novel app: a multivariable, cross-sectional study. BMJ Open, 14(7), Artikel e083065. https://doi.org/10.1136/bmjopen-2023-083065